GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
about
Endocrinopathies in survivors of childhood neoplasiaRisk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacementVolume increase in craniopharyngiomas under growth hormone and/or sex hormones substitution: Role of tumors receptors or mere coincidence?Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis.Growth hormone treatment in adults with growth hormone deficiency: the transition.How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?Hypothalamic obesity in children.Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.Diagnosis and treatment of growth hormone deficiency in adults.Management of craniopharyngiomas.Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity.Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.Prognostic factors of craniopharyngioma with special reference to autocrine/paracrine signaling: underestimated implication of growth hormone receptor.Is bariatric surgery really inefficient in hypothalamic obesity?
P2860
Q27009171-6900DB4F-08AB-433F-A1D8-B709A5CD80E9Q33570283-A4771536-5C24-4FE4-8727-3E2D8ABC982DQ35655119-B811CB4D-A30E-4DC9-A323-7C87165E747DQ36898845-1190D87C-047A-4F00-AFCA-B3711C89B285Q37198991-E6F8B425-3AEC-47E2-A63D-502670F1E7DFQ37697234-F4215018-A793-493A-8F73-163F24AB0D2DQ37832616-292263D5-6E97-4F0B-A14B-BD2FE27D8C7EQ37930510-22CF5997-D8F0-44A5-B5FA-C1BACAE7E5EDQ38009341-4A78F69C-A837-4A92-A988-F331A4121D05Q38014419-62043B83-C5CC-4A7D-B4AB-A4AF7E04B817Q38102923-86D62A89-2E02-435F-912F-60724D710E90Q38183324-C7BACDBC-972F-4B09-8DCE-2F8876D1FB97Q38205919-1E526B65-16E8-49AE-B5B3-23C3B0C5D86CQ38687230-5770C4B2-03E7-40F7-AF2F-C6430CF1F950Q46887493-B8594F36-68C3-414A-8B55-3B66F87CC16BQ48034166-8198DEE3-586C-45E0-A7C9-2CD71F77468DQ48369355-754B081C-D957-4ADB-89BF-607680BFDA4A
P2860
GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
GH replacement does not increa ...... tients with craniopharyngioma.
@en
GH replacement does not increa ...... tients with craniopharyngioma.
@nl
type
label
GH replacement does not increa ...... tients with craniopharyngioma.
@en
GH replacement does not increa ...... tients with craniopharyngioma.
@nl
prefLabel
GH replacement does not increa ...... tients with craniopharyngioma.
@en
GH replacement does not increa ...... tients with craniopharyngioma.
@nl
P2093
P2860
P1476
GH replacement does not increa ...... tients with craniopharyngioma.
@en
P2093
Anne Marland
Brian Shine
Fiona Ryan
Helen E Turner
John A H Wass
Justin T Warner
P2860
P304
P356
10.1111/J.1365-2265.2006.02508.X
P577
2006-05-01T00:00:00Z